Toyama, Japan

Sumie Yamaguchi

This inventor holds 1 USPTO granted patent. Top assignee: Toyama Chemical Co., Ltd.. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sumie Yamaguchi. Retrieved from https://idiyas.com/inventor/sumie-yamaguchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sumie Yamaguchi

Introduction

Sumie Yamaguchi is a notable inventor based in Toyama, Japan. She has made significant contributions to the field of chemistry, particularly in the development of compounds that have potential applications in medicine. Her work focuses on addressing nerve degeneration diseases, showcasing her commitment to improving health outcomes.

Latest Patents

Sumie Yamaguchi holds a patent for "N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same." This innovative patent highlights her expertise in creating chemical compounds that could lead to advancements in therapeutic treatments.

Career Highlights

Yamaguchi is associated with Toyama Chemical Co., Ltd., where she has been able to apply her research and development skills. Her work at the company has allowed her to collaborate with other talented professionals in the field, further enhancing her contributions to science and medicine.

Collaborations

Some of her notable coworkers include Satoshi Ono and Akihito Saitoh. Their collaboration has likely fostered a productive environment for innovation and research, leading to advancements in their respective fields.

Conclusion

Sumie Yamaguchi's work exemplifies the impact of innovative thinking in the realm of medical chemistry. Her patent and collaborations reflect her dedication to addressing critical health issues through scientific research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…